Background Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic ...
The Chosun Ilbo on MSN
Dongsan Hospital transforms centers into specialized maternal, cardiac, cancer hospitals
Recently, the medical systems of major university hospitals have evolved from a ‘specialized center’-based model to an ...
Percutaneous coronary intervention (PCI) is a standard treatment for significant coronary artery disease. Cardiologists use a ...
Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.
Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...
A liquid injected into the heart that sets like a gel could one day prevent strokes caused by atrial fibrillation, animal tests suggest.
A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...
The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...
7d
Global Cardiac Surgery Device Market to Reach $30.8 Billion by 2032, Led by Abbott – iData Research
Global cardiac surgery device market will grow from $21.1B in 2025 to $30.8B by 2032, driven by advances in imaging, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results